Phyto-Curcumin plus Enzymes
On sale on the US market (according to the DSLD)
Vital Nutrients, food supplement from the US market
Phyto-Curcumin plus Enzymes (Vital Nutrients), a food supplement au code-barres 693465278116, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
Source: Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), POL-NF-00692.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Vital Nutrients
- Barcode
- 693465278116
- Form
- Capsule
- One serving
- 3 vegetarian capsules
- Servings
- number of servings per day not stated
- Other ingredients (in English, as written)
- Cellulose, Magnesium Silicate, Cellulose, Silica, Leucine
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Curcumin Phytosome extract | Other substance | 1,275 mg |
| Bromelain | Enzyme | 150 mg |
| Serratiopeptidase | Enzyme | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Phyto-Curcumin plus Enzymes
Entered into DSLD on 23 August 2022. Withdrawn from the US market on 17 December 2021 (according to the DSLD).- Different quantity per serving : Bromelain: 100 mg in this version; 150 mg on the displayed label
- Different quantity per serving : Curcumin Phytosome Extract: 1,050 mg in this version; 1,275 mg on the displayed label
Official label: Phyto-Curcumin plus Enzymes
Entered into DSLD on 21 November 2019. Withdrawn from the US market on 7 December 2022 (according to the DSLD).- Different quantity per serving : Bromelain: 100 mg in this version; 150 mg on the displayed label
- Different quantity per serving : Curcumin Phytosome extract: 850 mg in this version; 1,275 mg on the displayed label
Official label: Phyto-Curcumin plus Enzymes
Entered into DSLD on 23 October 2019. Withdrawn from the US market on 5 April 2019 (according to the DSLD).- Different quantity per serving : Bromelain: 100 mg in this version; 150 mg on the displayed label
- Different quantity per serving : Curcumin Phytosome extract: 850 mg in this version; 1,275 mg on the displayed label
Official label: Phyto-Curcumin plus Enzymes
Entered into DSLD on 22 April 2016. Withdrawn from the US market on 5 April 2019 (according to the DSLD).- Active ingredient added : Curcuma longa rhizome extract (quantity not stated)
- Active ingredient added : Phosphatidylcholine (quantity not stated)
- Different quantity per serving : Bromelain: 100 mg in this version; 150 mg on the displayed label
- Different quantity per serving : Curcumin Phytosome extract: 1,050 mg in this version; 1,275 mg on the displayed label
Official label: Phyto-Curcumin plus Enzymes
Entered into DSLD on 25 November 2013. Withdrawn from the US market on 18 February 2016 (according to the DSLD).- Different quantity per serving : Bromelain: 50 mg in this version; 150 mg on the displayed label
- Different quantity per serving : Curcumin Phytosome Extract: 525 mg in this version; 1,275 mg on the displayed label
- Different unit, without conversion : Serratiopeptidase: 6,000 Unit(s) in this version; quantity not stated on the displayed label
Official label: Phyto-Curcumin plus Enzymes
Entered into DSLD on 23 March 2012. Withdrawn from the US market on 13 September 2013 (according to the DSLD).- Active ingredient added : Curcuma longa rhizome extract (quantity not stated)
- Active ingredient added : Phosphatidylcholine (quantity not stated)
- Different quantity per serving : Bromelain: 50 mg in this version; 150 mg on the displayed label
- Different quantity per serving : Curcumin Phytosome extract: 525 mg in this version; 1,275 mg on the displayed label
- Different unit, without conversion : Serratiopeptidase: 6,000 Unit(s) in this version; quantity not stated on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Serratiopeptidase
Read the warning, when it applies and the studies cited
SERRAPEPTASE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gastrointestinal lesions/ulcers, a kidney or liver disorder, or are having surgery (Bhagat et al. 2013; Chopra et al. 2009; Al- Khateeb and Nusair 2008; Mazzone et al. 1990).
Sources cited by Health Canada (4)
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
- Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
- Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
- Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or anti-inflammatory medications (Bhagat et al. 2013; Chopra et al. 2009; Al-Khateeb and Nusair 2008; Mazzone et al. 1990).
Sources cited by Health Canada (4)
- Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
- Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
- Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
Known adverse reactions
Stop use if rash, difficulty breathing, hypersensitivity and/or severe allergy occur (Bhagat et al. 2013; Balagi 2007).
Sources cited by Health Canada (1)
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Vital Nutrients
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Phyto-Curcumin plus Enzymes (Vital Nutrients): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/693465278116-phyto-curcumin-plus-enzymes-vital-nutrients, updated 24 January 2024.